Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

New combinations comprising roflumilast

Nov. 19, 2004

GSK-3beta inhibitors for the treatment of neurodegenerative diseases

Nov. 18, 2004

Protein kinase modulators claimed by Exelixis

Nov. 18, 2004

Vertex patent covers protein kinase inhibitors

Nov. 18, 2004

ARS investigators describe a new use of clusterin for peripheral neurological diseases

Nov. 18, 2004

New use of ritonavir for unconjugated hyperbilirubinemia claimed by Abbott

Nov. 18, 2004

Scientists at AmorePacific claim genistein for the treatment of obesity

Nov. 18, 2004

A series of fused pyrrole compounds described in a patent

Nov. 17, 2004

Three series of CGRP receptor antagonists claimed by Merck

Nov. 17, 2004

Merck patent claims bradykinin B1 receptor antagonist

Nov. 17, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 8, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 8, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...